BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7823608)

  • 1. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer.
    Anti M; Marra G; Percesepe A; Armelao F; Gasbarrini G
    J Cell Biochem Suppl; 1994; 19():68-75. PubMed ID: 7823608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel.
    Ponz de Leon M; Roncucci L; Di Donato P; Tassi L; Smerieri O; Amorico MG; Malagoli G; De Maria D; Antonioli A; Chahin NJ
    Cancer Res; 1988 Jul; 48(14):4121-6. PubMed ID: 3383201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative patterns of rectal mucosa as predictors of advanced colonic neoplasms in routinely processed rectal biopsies.
    Paspatis GA; Zizi A; Chlouverakis GJ; Giannikaki ES; Vasilakaki T; Elemenoglou I; Karamanolis DG
    Am J Gastroenterol; 1998 Sep; 93(9):1472-7. PubMed ID: 9732928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
    Biasco G; Paganelli GM; Santucci R; Brandi G; Barbara L
    J Cell Biochem Suppl; 1994; 19():55-60. PubMed ID: 7823606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients.
    Bostick RM; Fosdick L; Grandits GA; Lillemoe TJ; Wood JR; Grambsch P; Louis TA; Potter JD
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1011-9. PubMed ID: 9419396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps.
    Alberts DS; Einspahr J; Ritenbaugh C; Aickin M; Rees-McGee S; Atwood J; Emerson S; Mason-Liddil N; Bettinger L; Patel J; Bellapravalu S; Ramanujam PS; Phelps J; Clark L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):161-9. PubMed ID: 9138658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of proliferation indices as surrogate endpoint biomarkers.
    Alberts DS; Einspahr J; Aickin M; Hixson L; Earnest D; Roe D; Powell M
    J Cell Biochem Suppl; 1994; 19():76-83. PubMed ID: 7823609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of recommendations for colonic biomarker studies of candidate chemopreventive compounds in phase II clinical trials.
    Lipkin M
    J Cell Biochem Suppl; 1994; 19():94-8. PubMed ID: 7823612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of caloric restriction on colonic proliferation in obese persons: implications for colon cancer prevention.
    Steinbach G; Heymsfield S; Olansen NE; Tighe A; Holt PR
    Cancer Res; 1994 Mar; 54(5):1194-7. PubMed ID: 8118805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer.
    Paganelli GM; Lalli E; Facchini A; Biasco G; Santucci R; Brandi G; Barbara L
    Am J Gastroenterol; 1994 Feb; 89(2):220-4. PubMed ID: 8304307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.
    Sandler RS; Baron JA; Tosteson TD; Mandel JS; Haile RW
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):653-6. PubMed ID: 10919733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel.
    Scalmati A; Roncucci L; Ghidini G; Biasco G; Ponz de Leon M
    Cancer Res; 1990 Dec; 50(24):7937-41. PubMed ID: 2253235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
    Einspahr J; Alberts D; Xie T; Ritchie J; Earnest D; Hixson L; Powell M; Roe D; Grogan T
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal cell proliferation and colon cancer risk in ulcerative colitis.
    Biasco G; Paganelli GM; Miglioli M; Brillanti S; Di Febo G; Gizzi G; Ponz de Leon M; Campieri M; Barbara L
    Cancer Res; 1990 Feb; 50(4):1156-9. PubMed ID: 2297764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of the epithelial cell proliferative compartment and frequency of adenomatous polyps in the colon correlate with the strength of family history of colorectal cancer.
    Gerdes H; Gillin JS; Zimbalist E; Urmacher C; Lipkin M; Winawer SJ
    Cancer Res; 1993 Jan; 53(2):279-82. PubMed ID: 8417821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor alpha distribution in rectal crypts as a biomarker of decreased colon cancer risk in patients consuming cellulose.
    Hardman WE; Cameron IL; Beer WH; Speeg KV; Kadakia SC; Lang KA
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):633-7. PubMed ID: 9264277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
    Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
    Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.